Skip to content

A study to evaluate the efficacy of Haritakyadi Kwatha in the management of Pittaja Mutrakrichra

A randomised open-labelled controlled clinical study to evaluate the efficacy of Haritakyadi Kwatha in the management of Pittaja Mutrakrichra with special reference to Lower Urinary Tract Infection.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053645
Enrollment
30
Registered
2023-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Dr Akash Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The age group between 21 years – 60 years of either gender. Subjects fulfilling the diagnostic criteria. Subjects willing to participate with written informed consent , which is conveyed in the language to which the subject can understand.

Exclusion criteria

Exclusion criteria: Subjects diagnosed with obstructive pathology,upper urinary tract infections,BPH , sepsis ,chronic renal failure are excluded. Subjects having other uncontrolled systemic disorders which might interfere in course of disease and treatment are excluded. Presence of Oxalate crystals,RBC cells( >10 cells/hpf)will be excluded. Pregnant and lactating women are excluded.

Design outcomes

Primary

MeasureTime frame
1.Reduction of Pus cells,RBCs and getting negative urine culture (qualitative) and Reduction in signs and symptoms of Pittaja Mutrakrichra 1.Peeta mutrata 2.Sadaha mutrata 3.Krichra mutrata / Saruja mutrata 4.Muhurmuhur pravrutti 5.Sarakta mutrataTimepoint: 1.Pre-test assessment- 0th day,subjective and objective parameters will be assessed 2.Mid-test assessment-7th day,subjective parameters will be assessed 3.Post test assessment-14th day,subjective and objective parameters will be assessed 4.Follow up assessment-21st day,subjective parameters and objective parameters(Urine routine and microscopy if comes positive Urine culture will also be done)will be assessed

Secondary

MeasureTime frame
NIL Timepoint: NIL

Countries

India

Contacts

Public ContactDr Akash Gupta

Sri Sri College of Ayurvedic Science and Research Hospital

Lakshmimp1981@gmail.com9448173128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026